PODCAST

Neurology and Neurosurgery

ReachMD

science & medicine medicine

All Episodes

00:00:00

Recognizing MS: Understanding Symptoms and Avoiding...

Neurology and Neurosurgery ·

2025/08/20

Early symptoms of multiple sclerosis (MS) often present as clear, localized neurological changes lasting several days. However, many nonspecific complaints and common MRI findings can mimic MS, leading to misdiagnosis and unnecessary treatment. Dr. Jonathan Howard, an Associate Professor of Neurology and Psychiatry at the NYU Grossman School of Medicine and the Director of the Neurology Service at Bellevue Hospital, reviews hallmark symptom patterns, explains how to differentiate benign

00:00:00

Modern MS Care: Navigating Treatment Options for...

Neurology and Neurosurgery ·

2025/08/20

Since 2010, the landscape of multiple sclerosis care has transformed to encompass a variety of medications, each having unique benefits, risks, and side effect profiles. Dr. Jonathan Howard discusses how to match treatment strength to disease severity and balance patient risk tolerance with evolving therapeutic options, from long-standing injectables to infusions and oral therapies. Dr. Howard is an Associate Professor of Neurology and Psychiatry at the NYU Grossman School of Medicine and

00:00:00

Transforming Clinician Wellness: EEG Headphones...

Neurology and Neurosurgery ·

2025/06/30

Guest: John Golden Host: Michael Greenberg, MD Neuro-responsive EEG headphones are helping healthcare professionals combat burnout by promoting calm, focus, and resilience. Backed by neuroscience and real-time brain monitoring, this personalized technology blends music and neurofeedback to optimize mental states and reduce stress. Hear from Vital Neuro CEO John Golden as he joins Dr. Michael Greenberg to discuss this device's impact in clinical workflows, from pre-op anxiety

00:00:00

Tuning the Brain: Personalized Anxiety Relief with...

Neurology and Neurosurgery ·

2025/06/30

Guest: John Golden Guest: Michael Greenberg, MD EEG-guided headphones from Vital Neuro present a new frontier in anxiety management through personalized, real-time neurofeedback and music therapy. Dr. Michael Greenberg speaks with Vital Neuro CEO John Golden about the science behind these devices, their effectiveness in reducing anxiety symptoms, and how they can integrate into daily life.

00:00:00

Prioritizing Patient-Centered, Multidisciplinary Care...

Neurology and Neurosurgery ·

2025/06/30

Guest: Andrew G. Lee, MD Host: Ashley Baker, MSN, PMHNP Tailored, team-based care is essential for optimal outcomes in patients with chronic inflammatory demyelinating polyneuropathy (CIDP). Ashley Baker sits down with Dr. Andrew Lee to learn more about the diagnostic complexities of the disease, the critical role of neuro-opthalmology, and the importance of shared decision making in creating individualized care plans.

00:00:00

Identifying CIDP: A Guide to Risk Profiles and...

Neurology and Neurosurgery ·

2025/06/27

Guest: Nicolas Dubuisson, MD Host: Ryan Quigley Early recognition of CIDP is essential to prevent irreversible damage and guide appropriate treatment, but its varied presentations can complicate diagnosis. Ryan Quigley sits down with Dr. Nicolas Dubuisson to discuss the clinical hallmarks of CIDP, its variants, and key risk factors. Dr. Dubuisson is a Postdoctoral Researcher at the Nuffield Department of Clinical Neurosciences at Oxford University in England.

00:00:00

The Latest in Stroke Risk Reduction Strategies: Are...

Neurology and Neurosurgery ·

2025/06/11

Host: Alejandro A. Rabinstein, MD, FAHA Guest: Richard E. Pratley, MD Guest: Jay H. Shubrook, DO, FACOFP, FAAFP Listen to expert faculty discuss the role of GLP-1RAs in reducing stroke risk for patients with type 2 diabetes in this on-demand webcast with accompanying slides

00:00:00

New Frontiers in the Treatment of DMD Across the Age...

Neurology and Neurosurgery ·

2025/05/09

Host: Crystal Proud, MD Guest: John Brandsema, MD Guest: Omer Abdul Hamid, MD Explore the latest treatment options, age-specific management strategies, and clinical trial data for patients with Duchenne muscular dystrophy (DMD). Through expert-led discussions and real-world patient cases, you’ll gain practical insights to help you confidently navigate today’s ever-evolving treatment landscape and deliver personalized, informed care.

00:00:00

Supporting Adults With DMD: A Guide to Acute and...

Neurology and Neurosurgery ·

2025/05/08

Guest: Rosaline Quinlivan As patients with Duchenne muscular dystrophy (DMD) transition from pediatric to adult care, they may encounter healthcare professionals—from primary care to emergency medicine—without prior experience managing their condition. Explore critical gaps in adult services for DMD and gain practical insights to help deliver timely, informed, and compassionate care with Dr. Rosaline Quinlivan, Professor of Neuromuscular Disease at University College London.

00:00:00

Transitioning to Adult Care in DMD: Strategies for...

Neurology and Neurosurgery ·

2025/05/08

Guest: Rosaline Quinlivan From sustained therapy and emergency planning to psychological support, coordinated care is essential as patients with Duchenne muscular dystrophy (DMD) transition into adulthood. Explore multidisciplinary approaches to optimize function, independence, and quality of life in adults with DMD with Dr. Rosaline Quinlivan, Professor of Neuromuscular Disease at University College London.

00:00:00

Treatment Advances in Generalized Myasthenia Gravis:...

Neurology and Neurosurgery ·

2025/04/30

Host: Vera Bril, MD Guest: Neelam Goyal, MD Traditional therapies for generalized myasthenia gravis (gMG) have proven beneficial for many patients in the short term but often come with unacceptable side effects. The emergence of targeted inhibitors of the neonatal Fc receptor (FcRn) has created a groundbreaking paradigm shift in our approach to both the short- and longer-term management of affected patients. Join Drs. Vera Bril and Neelam Goyal as they take a deep dive into this

00:00:00

Improving Diagnostic Accuracy in MS: Criteria,...

Neurology and Neurosurgery ·

2025/04/25

Guest: Andrew J. Solomon, MD Accurately diagnosing multiple sclerosis (MS) involves understanding the diagnostic criteria, recognizing red flags to avoid misdiagnosis, and keeping up with new tools. Dr. Andrew Solomon, Professor and Interim Chair of the Department of Neurological Sciences and Chief of the Multiple Sclerosis Division at the University of Vermont, walks through the most difficult aspects of diagnosing patients with MS and potential breakthroughs reshaping how we approach

00:00:00

Mastering Migraine

Neurology and Neurosurgery ·

2025/04/16

Guest: Melody Barthelemy Guest: Dawn C. Buse, PhD Melody Barthelemy, a human resources specialist, details her experiences living with migraine, including strategies for tracking episodes and thriving with a busy career. She is joined by Dawn C. Buse, PhD, Clinical Professor, Albert Einstein College of Medicine, New York, NY, who discusses recent research in the field.

00:00:00

Engineering Autoimmunity: A New Model for Studying MS...

Neurology and Neurosurgery ·

2025/03/17

Guest: Christian Cordano, MD, PhD While multiple kinds of animal models are commonly used to study multiple sclerosis (MS), they are not always ideal for getting the full picture of the disease. To address these gaps, a new CAR T-cell-based model provides a reproducible disease course, discrete lesion formation, and an improved platform for testing remyelination therapies. Dr. Christian Cordano, Associate Researcher of Neurology at the University of California, San Francisco Weill

00:00:00

Proposed Hospital Standards for Parkinson Disease...

Neurology and Neurosurgery ·

2025/03/14

Unknown: Peter Pronovost, MD, PhD, FCCM Preventable harm is a serious concern for patients with Parkinson disease who receive care in the hospital setting, even when admitted for reasons other than their diagnosis. Peter Pronovost, MD, PhD, FCCM, Chief Quality and Transformation Officer at University Hospitals Cleveland Medical Center, Cleveland, OH, discusses his work with the Parkinson’s Foundation developing new hospital care standards for reducing medication mismanagement and

00:00:00

Safety Outcomes in MS Clinical Trials: Examining...

Neurology and Neurosurgery ·

2025/03/04

Guest: Amber Salter, PhD A recent study examined the association between comorbidities, adverse events, and early trial discontinuation in phase III clinical trials for disease-modifying therapies for multiple sclerosis. Join Dr. Amber Salter as she explains her findings and implications for clinical practice, including personalized treatment approaches. Dr. Salter is an Associate Professor of Biostatistics at UT Southwestern Medical Center, and she presented on this research at the

00:00:00

MS and the Ketogenic Diet: Potential Impacts on...

Neurology and Neurosurgery ·

2025/03/03

Guest: Michael Kornberg, MD, PhD A recent study found that a ketogenic diet may have anti-inflammatory effects in patients with multiple sclerosis (MS), potentially reducing relapse risk. However, this diet also comes with a variety of risks and challenges. Hear from Dr. Michael Kornberg as he explains the potential benefits and drawbacks of this approach. Dr. Kornberg is an Assistant Professor of Neurology at Johns Hopkins University School of Medicine, and he presented on this topic

00:00:00

MS and Structural Disconnectivity: Pathophysiology...

Neurology and Neurosurgery ·

2025/02/27

Guest: Amy Kuceyeski, PhD In patients with multiple sclerosis, lesions in white matter can disrupt brain connectivity, leading to cognitive and motor impairments. Join Dr. Amy Kuceyeski as she discusses the pathophysiology behind structural disconnectivity and shares insights on new tools being developed to more accurately identify it in patients with multiple sclerosis. Dr. Kuceyeski is a Professor of Mathematics in Radiology and Neuroscience at Weill Cornell Medicine, and she spoke

00:00:00

Emerging Technologies in MS: Neuromodulation and...

Neurology and Neurosurgery ·

2025/02/27

Guest: Cristin Welle, PhD To address the concerning effects of demyelinating events in patients with multiple sclerosis (MS), a recent study explored whether neuromodulation could support myelin repair and restoration of function. Learn more as Dr. Cristin Welle explains how vagus nerve stimulation has the potential to play a role in remyelination. Dr. Cristin Welle is a Professor of Neurosurgery and Physiology at the University of Colorado Anschutz Medical Campus, and she spoke about

00:00:00

Understanding Prodromal Phases in Demyelinating...

Neurology and Neurosurgery ·

2025/02/27

Guest: Dalia Rotstein, MD, MPH Prodromal symptoms are common in neurologic and inflammatory conditions like multiple sclerosis (MS). Recent evidence suggests that prodromal symptoms also exist in patients with neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody disease (MOGAD). Join Dr. Dalia Rotstein as she explains how emerging research is providing insight into these symptoms, potentially informing our diagnostic strategies.

141 results

Neurology and Neurosurgery

All Episodes

Similar Podcasts

Eye On The Sky

Vermont Public

Cienciaes.com

cienciaes.com

This Week in Virology

Vincent Racaniello

Hablando con Científicos - Cienciaes.com

cienciaes.com

The Elective Rotation: A Critical Care Hospital Pharmacy Podcast

Pharmacy Joe